SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001628280-17-001304
Filing Date
2017-02-14
Accepted
2017-02-14 14:05:30
Documents
1
Group Members
ALLIANZ GLOBAL INVESTORS GMBHALLIANZ GLOBAL INVESTORS U.S. HOLDINGS LLCALLIANZ GLOBAL INVESTORS U.S. LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G agi-anipharmaceuticalsinc1.htm SC 13G 96029
  Complete submission text file 0001628280-17-001304.txt   97821
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 17606835
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 212-739-3000
Allianz Global Investors U.S. Holdings LLC (Filed by) CIK: 0001567940 (see all company filings)

IRS No.: 330977088 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G